北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 1067-1073. doi: 10.3969/j.issn.1671-167X.2016.06.025

• 技术方法 • 上一篇    下一篇

不同工艺制备BCSⅡ类药物固体分散体的性质

时念秋1,2△,张鸿1,张勇2,冯波1,李正强2,齐宪荣3△   

  1. (1. 吉林医药学院,吉林省 吉林市 132013;2. 吉林大学生命科学学院, 长春 130012;3. 北京大学药学院, 北京 100191)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 时念秋,齐宪荣 E-mail:shinianqiu2009@163.com, qixr@bjmu.edu.cn
  • 基金资助:

    国家自然科学基金(81602654)、吉林市科技发展计划项目(201464053)、吉林省教育厅项目(吉教科合字2015第401号)、中国博士后科学基金项目(2015M571374)和吉林省科技发展计划项目(20140311110YY、20160520046JH)资助

Study on the properties of felodipine solid dispersions prepared by different technologies

SHI Nian-qiu1,2△, ZHANG Hong1, ZHANG Yong2, FENG Bo1, LI Zheng-qiang2, QI Xian-rong3△   

  1. (1. Jilin Medical University, Jilin 132013, Jilin, China; 2. School of Life Science, Jilin University, Changchun 130012, China; 3. School of Pharmaceutical Science, Peking university, Beijing 100191, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: SHI Nian-qiu,QI Xian-rong E-mail:shinianqiu2009@163.com, qixr@bjmu.edu.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China (81602654), the Jilin City Science and Technology Development Project (201464053), the Project of Education Department of Jilin Province (2015401), China Postdoctoral Science Foundation (2015M571374), and Jilin Province Science and Technology Development Project (20140311110YY,20160520046JH)

摘要:

目的:制备生物药剂学分类系统Ⅱ(Biopharmaceutics Classification SystemⅡ, BCS Ⅱ)类药物非洛地平固体分散体,并比较各非洛地平固体分散体的性质。方法: 主要通过喷雾干燥法、微波淬冷法、冷冻干燥法和共沉淀法制备非洛地平/共聚维酮固体分散体,利用扫描电子显微镜(scanning electron microscope,SEM)、差式扫描量热(differential scanning calorimetry,DSC)和粉末X射线(X-ray diffraction,XRD)对所得固体分散体进行内在无定型性质分析,通过溶出实验来研究各工艺所得非洛地平固体分散体改善药物难溶性质的特征,通过超饱和实验研究聚合物对超饱和药物的结晶抑制效应。结果: 喷雾干燥法、微波淬冷法及共沉淀法所得固体分散体内部药物以无定型形式存在,冷冻干燥法所得固体分散体内部药物以微晶形式存在。微波淬冷法比其他方法更能显著地改善难溶性药物非洛地平的溶出(P<0.05),60 min后溶出达到4.65 mg/L。共聚维酮能延缓或抑制超饱和非洛地平的结晶,在预溶最大量共聚维酮的溶液中,超饱和非洛地平在240 min时的结晶速率最小,为0.19 mg/(L·min)。结论:阐明了不同工艺所制得固体分散体的内在性质,为难溶性药物固体分散体的实际生产工艺选择提供参考。

关键词:  , 非洛地平, 药物制备, 溶解度, 固体分散体

Abstract:

Objective: To prepare felodipine/copovidone solid dispersions, which were made based on different preparation technologies. Insoluble felodipine was selected as the model drug in this research. This drug belonged to Biopharmaceutics Classification System Ⅱ (BCSⅡ) with insoluble property and good permeability across intestinal mucosa simultaneously. A comparative study was carried out for further investigating their corresponding pharmaceutical properties. Methods: Felodipine/copovidone solid dispersions were achieved by four methods including spray-drying method, microwave-induced fusion quench cooling method, freeze-drying method and co-precipitation method. These solid dispersions were produced based on corresponding processes that corresponded to these methods. Internal properties of co-povidone solid dispersions were analyzed by various approaches including scanning electron microscope (SEM), differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). The improvement on insoluble properties of felodipine by solid dispersions produced by different technologies was characterized by dissolution experiments based on dissolution instrument. Crystallization inhibition effect of polymers against drugs was studied by supersaturated experiments through determining the concentration value at different time points. Results: The internal drug was dispersed in amorphous form in solid dispersions produced by spray-drying, microwave method, microwave/quench-cooling method and co-precipitation method. Freeze-drying method resulted in a form of crystal in felodipine/copovidone solid dispersions. Compared with other technologies, microwave-induced quench cooling method could significantly improve the dissolution of insoluble drug felodipine (P<0.05). The dissolution concentration reached approximately 4.65 mg/L at 60 min time point. Copovidone could inhibit or retard the crystallization of felodipine in a supersaturated state. In the solution pre-dissolved with maximum copoyidone po-lymer, the minimum crystallization rate of supersaturated felodipine was observed at 240 min time point. The value of crystallization rate was 0.19 mg/(L·min). Conclusion: The study is helpful to understand and clarify the internal properties of solid dispersions obtained by different technologies. The research also provides beneficial consultation for the choice of technology in practical production of drug-polymer solid dispersions.

Key words: Felodipine, Drug preparation, Solubility, Solid dispersions

中图分类号: 

  • R943
[1] 李刚,王健生,秦思达,张佳,杜宁,张靖,孙欣,任宏. 布地奈德联合氨溴索氧化驱动雾化吸入预防成人开胸术后肺炎的临床疗效[J]. 北京大学学报(医学版), 2018, 50(5): 840-844.
[2] 倪莲芳,王鹤,李虹,张志刚,刘新民. 非人类免疫缺陷病毒感染肺隐球菌病34例临床分析[J]. 北京大学学报(医学版), 2018, 50(5): 855-860.
[3] 王芳芳,杨殷杰,侯晓玫. 电火花蚀刻镍钛根管锉HyFlex EDM的表面形态和抗疲劳折断性能[J]. 北京大学学报(医学版), 2018, 50(5): 876-881.
[4] 王昊,陈亮,叶小云. 雷公藤甲素对TM4细胞氧化应激及PI3K/AKT通路的影响[J]. 北京大学学报(医学版), 2018, 50(4): 607-612.
[5] 王建伟,满立波,黄广林,王海,徐啸,朱晓斐,李玮,刘振华. 经会阴三步法手术策略治疗单纯性男性骨盆骨折后尿道离断[J]. 北京大学学报(医学版), 2018, 50(4): 617-620.
[6] 唐兴国,颜野,邱敏,卢剑,陆敏,侯小飞,黄毅,马潞林. 单中心16年青年膀胱尿路上皮癌患者的诊治[J]. 北京大学学报(医学版), 2018, 50(4): 630-633.
[7] 吴恺,张杨,张红,檀增桓,郭晓蕙,杨建梅. 嗜铬细胞瘤/副神经节瘤患者RET、VHL、SDHD、SDHB遗传基因变异的检测[J]. 北京大学学报(医学版), 2018, 50(4): 634-639.
[8] 吴鹏辉,谢瑶,赵卫红,华瑛,孙青,李硕,吴晔,卢新天. 血液病/肿瘤患儿并发可逆性后部白质脑病综合征[J]. 北京大学学报(医学版), 2018, 50(4): 662-665.
[9] 徐奔,张喆楠,罗程,宋海峰,张骞. 后腹腔镜下肿瘤吸除术与肾部分切除术治疗肾血管平滑肌脂肪瘤的安全性与有效性对比[J]. 北京大学学报(医学版), 2018, 50(4): 700-704.
[10] 郝一昌,侯小飞,赵磊,肖春雷,刘茁,张帆,马潞林. 全腹腔镜移植输尿管膀胱再植术处理肾移植术后输尿管狭窄[J]. 北京大学学报(医学版), 2018, 50(4): 705-710.
[11] 覃子健,毕海,马潞林,黄毅,张帆. 肠代膀胱内原发肠源性腺癌1例[J]. 北京大学学报(医学版), 2018, 50(4): 737-739.
[12] 张慧峰,黄焕焕,赵雨佳,李清如,祁宇泽,周辉. 苯并[a]芘对神经胶质细胞中胰岛素降解酶与脑啡肽酶表达的影响[J]. 北京大学学报(医学版), 2018, 50(3): 401-407.
[13] 林鸿波,陈奕,沈鹏,李小勇,司亚琴,张杜丹,唐迅,高培. 社区糖尿病患者慢性肾脏病的发病率及其危险因素[J]. 北京大学学报(医学版), 2018, 50(3): 416-421.
[14] 张艺潇,冯文. 决策树在贫困农村老人就诊影响因素中的应用[J]. 北京大学学报(医学版), 2018, 50(3): 450-456.
[15] 孙颖,靳蕾. 中国北方3县妊娠妇女血液锰浓度及其影响因素[J]. 北京大学学报(医学版), 2018, 50(3): 463-468.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!